Paid Clinical Trials Bakersfield

Discover 85 paid clinical trials in Bakersfield, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 85

Treatment for GlaucomaA Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes

Recruiting

PHASE1

Sponsor:

Amneal Pharmaceuticals, LLC

Location:

Bakersfield CA, Newport Beach CA, Houston TX, Morrow GA

Code:

NCT06267274

Conditions

Open-angle Glaucoma

Ocular Hypertension

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bimatoprost Ophthalmic Solution, 0.01%

LUMIGAN® (bimatoprost ophthalmic solution) 0.01%

MilvexianA Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

Recruiting

PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Bakersfield CA, Northridge CA, Pasadena CA, Santa Monica CAshow 163 more

Code:

NCT05754957

Conditions

Acute Coronary Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Milvexian

Placebo

SaruparibSaruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Bakersfield CA, Santa Barbara CA, Pasadena CA, Santa Monica CAshow 115 more

Code:

NCT06120491

Conditions

Metastatic Castration-Sensitive Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Saruparib

Placebo

Abiraterone Acetate

Darolutamide

Enzalutamide

BrepocitinibA Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis

Recruiting

PHASE3

Sponsor:

Priovant Therapeutics, Inc.

Location:

Bakersfield CA, Beverly Hills CA, Los Angeles CA, Fullerton CAshow 33 more

Code:

NCT06431373

Conditions

Uveitis, Posterior

Uveitis, Intermediate

Uveitis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Brepocitinib PO QD

Placebo PO QD

GIM-531Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors

Recruiting

PHASE1

PHASE2

Sponsor:

Georgiamune Inc

Location:

Bakersfield CA, Los Angeles CA, Fullerton CA, San Francisco CAshow 6 more

Code:

NCT06425926

Conditions

Melanoma Stage IV

Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

GIM-531

Anti-PD-1 monoclonal antibody

VX-993Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy

Recruiting

PHASE2

Sponsor:

Vertex Pharmaceuticals Incorporated

Location:

Bakersfield CA, La Mesa CA, Meridian ID, Wheat Ridge COshow 23 more

Code:

NCT06619860

Conditions

Diabetic Peripheral Neuropathic Pain

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

VX-993

Pregabalin

Placebo (matched to pregabalin)

Placebo (matched to VX-993)

Amivantamab & CetuximabA Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

Recruiting

PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Bakersfield CA, Los Angeles CA, Torrance CA, Los Alamitos CAshow 21 more

Code:

NCT06750094

Conditions

Colorectal Neoplasms

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Amivantamab

Cetuximab

Bevacizumab

5-fluorouracil

Leucovorin calcium/Levoleucovorin

V940 & BCGA Clinical Study of V940 and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Recruiting

PHASE2

Sponsor:

Merck Sharp & Dohme LLC

Location:

Bakersfield CA, Torrance CA, Los Alamitos CA, Austin TXshow 1 more

Code:

NCT06833073

Conditions

Urinary Bladder Neoplasms

Non-Muscle Invasive Bladder Neoplasms

Carcinoma in Situ

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

V940

BCG

MK-1084 & PembrolizumabA Study of MK-1084 Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant, Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004)

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Bakersfield CA, Beverly Hills CA, Billings MT, Houston TXshow 11 more

Code:

NCT06345729

Conditions

Non-small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MK-1084

Placebo

Pembrolizumab

Cognitive TrainingCognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Recruiting

Sponsor:

NRG Oncology

Location:

Bakersfield CA, Santa Maria CA, Arroyo Grande CA, Burbank CAshow 433 more

Code:

NCT05896189

Conditions

Breast Cancer

Cognitive Impairments

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Arm 1: Computerized Cognitive Training-Global Stimulation Games

Arm 2: Computerized Cognitive Training-Neuroplasticity Games